Treatment of parainfluenza virus 3 pneumonia in a cardiac transplant recipient with intravenous ribavirin and methylprednisolone

J Heart Lung Transplant. 2005 Mar;24(3):343-6. doi: 10.1016/j.healun.2004.01.003.

Abstract

A 59-year-old man developed a lower respiratory tract infection 10 years after orthotopic cardiac transplantation. He did not respond to broad-spectrum antibiotic and antifungal treatment. Parainfluenza virus type 3 was the causative organism, and he was successfully treated with intravenous ribavirin and methylprednisolone.

Publication types

  • Case Reports

MeSH terms

  • Antiviral Agents / administration & dosage
  • Antiviral Agents / therapeutic use*
  • Glucocorticoids / administration & dosage
  • Glucocorticoids / therapeutic use*
  • Heart Transplantation*
  • Humans
  • Male
  • Methylprednisolone / administration & dosage
  • Methylprednisolone / therapeutic use*
  • Middle Aged
  • Parainfluenza Virus 3, Human*
  • Pneumonia, Viral / drug therapy*
  • Radiography
  • Respirovirus Infections / diagnostic imaging
  • Respirovirus Infections / drug therapy*
  • Ribavirin / administration & dosage
  • Ribavirin / therapeutic use*

Substances

  • Antiviral Agents
  • Glucocorticoids
  • Ribavirin
  • Methylprednisolone